Table 2.

CTL-suppressive macrophages are M2 oriented


Gene product

Accession no.

P/N

Function
P/N at least 2    
    FIZZ1  NM_020509  438.3 ± 245.9   Lipid and sugar metabolism  
    Ym  NM_009892 (Ym1); NM_145126 (Ym2)   357.3 ± 163.3   Lectin  
    Fibronectin-1  NM_010233  101.3 ± 6.9   Wound healing  
    Arginase-1  NM_007482  95.6 ± 39.4   Wound healing, immunomodulation/ROS production  
    CCL8 (MCP-2)  NM_021443  17.7 ± 5.2   Th2-type chemotaxis  
    CCL24 (eotaxin-2)  NM_019577  12.0 ± 5.2   Th2-type chemotaxis  
    E-cadherin  NM_009864  11.9 ± 6.6   Cell-cell adhesion  
    MGL-1  NM_010796  10.3 ± 2.0   C-type lectin (pattern recognition)  
    MGL-2  NM_145137  9.5 ± 0.8   C-type lectin (pattern recognition)  
    Selenoprotein P  NM_009155  8.5 ± 2.5   Anti-inflammation  
    Coagulation factor XIIIa  NM_028784  5.0 ± 1.2   Wound healing  
    Retinoic acid Rγ NM_011244  4.7 ± 2.1   Transcription factor  
    PD-L2  NM_021396  4.6 ± 2.0   Immunomodulation  
    TREM-2b  AY024349  4.6 ± 2.5   Pattern recognition  
    PLA2GIVa  NM_008869  4.1 ± 1.4   cPLA2; arachidonic acid metabolism  
    Cathepsin L  NM_009984  3.7 ± 0.9   Antigen processing  
    PLA2GVII/PAF-AH  NM_013737  3.5 ± 0.8   Anti-inflammation (arachidonic acid metabolism)  
    Macrophage mannose receptor  NM_008625  3.3 ± 1.0   C-type lectin (pattern recognition)  
    Prosaposin  NM_011179  2.9 ± 0.6   Sphingolipid metabolism  
    Cysteinyl leukotriene R1  NM_021476  2.7 ± 0.6   Immunomodulation (arachidonic acid metabolism)  
    PPARγ NM_011146  2.4 ± 0.4   Lipid metabolism, anti-inflammation (arachidonic acid metabolism)  
P/N less than 2    
    iNOS  NM_010927  0.6 ± 0.2   NO/ROS production  
    12/15-lipoxygenase  NM_007440  0.8 ± 0.3   Anti-inflammation (arachidonic acid metabolism)  
    PLA2GIId  NM_011109  0.9 ± 0.2   sPLA2, arachidonic acid metabolism  
    PLA2GV  NM_011110  1.5 ± 0.5   sPLA2, arachidonic acid metabolism  
    PLA2GXIIa  NM_023196  1.6 ± 0.4   sPLA2, arachidonic acid metabolism  
    PLA2GVIa
 
NM_016915
 
2.0 ± 0.5
 
iPLA2, arachidonic acid metabolism
 

Gene product

Accession no.

P/N

Function
P/N at least 2    
    FIZZ1  NM_020509  438.3 ± 245.9   Lipid and sugar metabolism  
    Ym  NM_009892 (Ym1); NM_145126 (Ym2)   357.3 ± 163.3   Lectin  
    Fibronectin-1  NM_010233  101.3 ± 6.9   Wound healing  
    Arginase-1  NM_007482  95.6 ± 39.4   Wound healing, immunomodulation/ROS production  
    CCL8 (MCP-2)  NM_021443  17.7 ± 5.2   Th2-type chemotaxis  
    CCL24 (eotaxin-2)  NM_019577  12.0 ± 5.2   Th2-type chemotaxis  
    E-cadherin  NM_009864  11.9 ± 6.6   Cell-cell adhesion  
    MGL-1  NM_010796  10.3 ± 2.0   C-type lectin (pattern recognition)  
    MGL-2  NM_145137  9.5 ± 0.8   C-type lectin (pattern recognition)  
    Selenoprotein P  NM_009155  8.5 ± 2.5   Anti-inflammation  
    Coagulation factor XIIIa  NM_028784  5.0 ± 1.2   Wound healing  
    Retinoic acid Rγ NM_011244  4.7 ± 2.1   Transcription factor  
    PD-L2  NM_021396  4.6 ± 2.0   Immunomodulation  
    TREM-2b  AY024349  4.6 ± 2.5   Pattern recognition  
    PLA2GIVa  NM_008869  4.1 ± 1.4   cPLA2; arachidonic acid metabolism  
    Cathepsin L  NM_009984  3.7 ± 0.9   Antigen processing  
    PLA2GVII/PAF-AH  NM_013737  3.5 ± 0.8   Anti-inflammation (arachidonic acid metabolism)  
    Macrophage mannose receptor  NM_008625  3.3 ± 1.0   C-type lectin (pattern recognition)  
    Prosaposin  NM_011179  2.9 ± 0.6   Sphingolipid metabolism  
    Cysteinyl leukotriene R1  NM_021476  2.7 ± 0.6   Immunomodulation (arachidonic acid metabolism)  
    PPARγ NM_011146  2.4 ± 0.4   Lipid metabolism, anti-inflammation (arachidonic acid metabolism)  
P/N less than 2    
    iNOS  NM_010927  0.6 ± 0.2   NO/ROS production  
    12/15-lipoxygenase  NM_007440  0.8 ± 0.3   Anti-inflammation (arachidonic acid metabolism)  
    PLA2GIId  NM_011109  0.9 ± 0.2   sPLA2, arachidonic acid metabolism  
    PLA2GV  NM_011110  1.5 ± 0.5   sPLA2, arachidonic acid metabolism  
    PLA2GXIIa  NM_023196  1.6 ± 0.4   sPLA2, arachidonic acid metabolism  
    PLA2GVIa
 
NM_016915
 
2.0 ± 0.5
 
iPLA2, arachidonic acid metabolism
 

Splenocytes from 3 individual BW-Sp3 progressors and 2 individual naive mice were restimulated in vitro with irradiated BW-Sp3(B7-1) for 5 days, after which RNA was extracted and cDNA prepared from the adherent splenocytes. Expression of each of the listed genes was determined via quantitative real-time PCR and normalized for the housekeeping gene ribosomal protein S12. The fold induction of gene expression (mean ± SD of 3 individual mice) in progressor compared with naive adherent splenocytes (mean ± SD of 2 individual mice) is shown (P/N).

P/N at least 2 indicates all tested genes with a minimal 2-fold induction in progressor adherent splenocytes, a criterion that is not met by the genes listed under P/N less than 2.

Close Modal

or Create an Account

Close Modal
Close Modal